Key result
Genetically higher triglycerides linked to ~102% greater acute pancreatitis risk.
Why the study?
Although lipid levels, particularly triglycerides, are associated with acute pancreatitis, their causalities and potential bidirectional relationships have not been fully examined.
Do genetically predicted abnormal lipid levels (TG, HDL-C, LDL-C) increase the risk of acute pancreatitis, and does acute pancreatitis alter lipid levels?
Observational (n=421,181)
Yes
Do genetically predicted abnormal lipid levels (TG, HDL-C, LDL-C) increase the risk of acute pancreatitis, and does acute pancreatitis alter lipid levels?
Odds Ratio: 2.02 (95% CI 1.22–3.31)
Higher genetically predicted triglycerides and lower HDL-C are causal risk factors for acute pancreatitis, suggesting lipid modulation may help prevent the disease.
Supports lipid management as potential pancreatitis prevention strategy; extends observational links with Mendelian randomization evidence.
Previous studies found lipid levels, especially triglycerides (TG), are associated with acute pancreatitis, but their causalities and bi-directions were not fully examined. We determined whether abnormal levels of TG, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) are precursors and/or consequences of acute pancreatitis using bidirectional two-sample Mendelian randomization (MR) with two non-overlapping genome-wide association study (GWAS) summary statistics for lipid levels and acute pancreatitis. We found phenotypic associations that both higher TG levels and lower HDL-C levels contributed to increased risk of acute pancreatitis. Our GWAS meta-analysis of acute pancreatitis identified seven independent signals. Genetically predicted TG was positively associated with acute pancreatitis when using the variants specifically associated with TG using univariable MR [Odds ratio (OR), 95% CI 2.02, 1.22-3.31], but the reversed direction from acute pancreatitis to TG was not observed (mean difference = 0.003, SE = 0.002, P-value = 0.138). However, a bidirectional relationship of HDL-C and acute pancreatitis was observed: A 1-SD increment of genetically predicted HDL-C was associated with lower risk of acute pancreatitis (OR, 95% CI 0.84, 0.76-0.92) and genetically predisposed individuals with acute pancreatitis have, on average, 0.005 SD lower HDL-C (mean difference = - 0.005, SE = 0.002, P-value = 0.004). Our MR analysis confirms the evidence of TG as a risk factor of acute pancreatitis but not a consequence. A potential bidirectional relationship of HDL-C and acute pancreatitis occurs and raises the prospect of HDL-C modulation in the acute pancreatitis prevention and treatment.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) conducted an observational in Acute pancreatitis (n=421,181). Genetically predicted triglyceride and HDL-C levels vs. Unexposed/reference genetic profile was evaluated on Risk of acute pancreatitis per 1-SD increment in genetically predicted log-transformed triglycerides (OR 2.02, 95% CI 1.22-3.31). Genetically predicted higher triglyceride levels were associated with an increased risk of acute pancreatitis (OR 2.02), while higher HDL-C levels were associated with a decreased risk (OR 0.84).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: